Move will add surgical imaging system to product portfolio.
Carestream Health and Ziehm Imaging announced a partnership on April 19 that will add a mobile C-arm to the Carestream product portfolio.
The mobile C-arm, known as the Ziehm Vision RFD C-arm is a surgical imaging system that will expand Carestream’s mobile and fluoroscopic capabilities.
“The partnership with Carestream confirms Ziehm Imaging’s industry-leading technology,” said Nelson Mendes, president and chief executive officer of Orthoscan and Ziehm Imaging, Inc. “As a result of this partnership, we’re able to provide Carestream and its customers with one of the most innovate C-arms on the market.”
Credit: Carestream
The Vision RFD C-arm is outfitted with a 25-kilowatt generator in either a 20.5 x 20.5 cm or 31 cm x 31 cm field-of-view flat-panel CMOS digital detector. Not only does it allow for general surgical applications, but it can also provide for vascular, cardiac, spine ortho-trauma, and pain management procedural work.
According to company officials, the product’s Advanced Active Cooling system can extend case times beyond what is possible with traditional air-cooled systems. Its graphical interface is intuitive and can reduce training times and increase productivity, they said. By using SmartDose, it also reduces exposure.
Vision RFD systems will be available in the United States and Canada this year with sale and service available through Carestream.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.